April 27, 2017 3:16 PM ET

Healthcare Equipment and Supplies

Company Overview of Ekso Bionics Holdings, Inc.

Company Overview

Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, military, and consumer markets in North America, Europe, the Middle East, and Africa. The company operates through Medical Devices, Industrial Sales, and Engineering Services segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, hemiplegia due to stroke, and lower limb paralysis or weakness. The company’s Ekso device is primarily used in a clinic or rehabilitation setting. It also performs research and development work on human exo...

1414 Harbour Way South

Suite 1201

Richmond, CA 94804

United States

Founded in 2005

103 Employees

Phone:

510-984-1761

Fax:

510-927-2647

Key Executives for Ekso Bionics Holdings, Inc.

Chief Executive Officer, President and Director
Age: 44
Total Annual Compensation: $225.0K
Co-Founder and President of Ekso Labs Division
Age: 39
Total Annual Compensation: $225.0K
Chief Financial Officer
Age: 54
Total Annual Compensation: $225.0K
Compensation as of Fiscal Year 2015.

Ekso Bionics Holdings, Inc. Key Developments

Ekso Bionics Holdings, Inc. Appoints Howard Palefsky to its Board of Directors

Ekso Bionics Holdings, Inc. announced that Howard Palefsky has been appointed to its board of directors, effective immediately. Howard Palefsky is a veteran in the healthcare industry who has extensive experience as an entrepreneur, CEO, board chair, director and investor in the life sciences, including medical devices. Mr. Palefsky is currently an active advisor or board member to multiple companies in the healthcare arena, including Olatec Therapeutics, Adigica Health, Life Sciences Alternative Funding and Victoria Capital Management. Previously, he was a managing director at Montreux Equity Partners as well as chairman and CEO of NeurogesX.

Ekso Bionics Holdings, Inc. Auditor Raises 'Going Concern' Doubt

Ekso Bionics Holdings, Inc. filed its 10-K on Mar 15, 2017 for the period ending Dec 31, 2016. In this report its auditor, Odenberg Ullakko Muranishi & Co LLP - OUM & Co LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Ekso Bionics Holdings, Inc. Announces Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2016

Ekso Bionics Holdings, Inc. announced consolidated earnings results for the fourth quarter and full year ended December 31, 2016. For the quarter, the company announced total revenue was $2,587,000 compared to $1,943,000 for the same period a year ago. Loss from operations was $6,682,000 compared to $6,652,000 for the same period a year ago. Net loss applicable to common shareholders was $5,576,000 compared to $9,300,000 for the same period a year ago. Diluted net loss per share applicable to common shareholders was $0.35 compared to $0.63 for the same period a year ago. For the full year, the company announced total revenue was $14,221,000 compared to $8,661,000 for the same period a year ago. Loss from operations was $27,586,000 compared to $21,561,000 for the same period a year ago. Net loss applicable to common shareholders was $33,815,000 compared to $24,245,000 for the same period a year ago. Diluted net loss per share applicable to common shareholders was $2.05 compared to $1.83 for the same period a year ago.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ekso Bionics Holdings, Inc., please visit www.eksobionics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.